Thanks for reading. Stay tuned to our blog each week for more highlights.
Dealcloser Blog Roundup November 14
Because you can’t follow all of the dealmaking updates, we do it for you. This week features deal volume, EMEA, and life sciences M&A trends.
15 November 2014
Welcome to your guide on the most interesting M&A, corporate development, alternative investments and debt capital markets news and events.
Because you can’t follow all of the dealmaking updates, we do it for you. Each week we will share the top stories featured on our blog to catch you up to speed. Check these out …
- Worldwide deal volume hit $2.8 trillion in the first nine months of 2014 — the highest level since 2007, and a 34 percent year-on-year rise, notes the WSJ. With all of this M&A activity, boutique advisory firms have been doing quite well, too.
- France lately has been a major force in the resurgent European market, says the WSJ. For example, consider French advertising behemoth Publicis Groupe’s $3.7 billion bid for U.S. based marketing and media firm Sapient.
- Recently, dealmaking has been big factor in Big Pharma, as the Economist points out. The M&A reasons vary: sometimes they are useful to swap assets between companies; at other times, a deal injects innovation into a drug company's development pipeline. In any case, the article cites a study that indicates that (over the past 20 years) the top performing drug firms derived 70 percent of their revenues from pharmaceuticals developed by third parties.
- Speaking of Big Pharma deals, Reuters notes how the failed $55 billion merger of U.K. drug maker Shire and U.S. counterpart AbbVie has had far-ranging effects on some hedge funds. That debacle, along with another 500 deals that collapsed in 2014, caused investors to pull $3.3 billion out of M&A-focused hedge funds in just the last two months.
- And back to our ongoing series of how to turn around distressed companies … This blog explains the need for stakeholders to link together, come clean about the realities of the situation, and not permit surprises. Really, except for Halloween, nobody likes a scare.
Marc Songini has worked in the information technology field for more than 16 years. His roles have included those of journalist, analyst, and marketing communications specialist. He admits that when he started out as a cub high tech reporter, Netscape was still rocking the industry with a wondrous new user interface called a “browser.” During his 10 years with International Data Group (IDG), Marc wrote for NetworkWorld and Computerworld, both award-winning magazines. Marc specializes in cloud, enterprise apps, and figuring out the meaning of being human in an automated world.